GenoFocus Inc
HLB Genex, Inc. engages in the research and development, production, import/export, and sale of enzymes and fermentation products in South Korea and internationally. Its industrial special enzyme products include lactase; catalase for use in semiconductor industry; and proteinase K for molecular diagnostics and genetic engineering experiments, as well as bio-health care ingredients comprise N-phy… Read more
GenoFocus Inc (187420) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.037x
Based on the latest financial reports, GenoFocus Inc (187420) has a cash flow conversion efficiency ratio of 0.037x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.68 Billion) by net assets (₩44.88 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
GenoFocus Inc - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how GenoFocus Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
GenoFocus Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of GenoFocus Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Trk Corp
TW:1432
|
0.076x |
|
Vittia Fertilizantes
SA:VITT3
|
0.172x |
|
H&R GmbH & Co. KGaA
XETRA:2HRA
|
0.054x |
|
Ditas Dogan Yedek Parca Imalat ve Teknik AS
IS:DITAS
|
-0.443x |
|
Cardlytics Inc
NASDAQ:CDLX
|
-0.374x |
|
Lotus Bakeries NV
PINK:LOTBY
|
0.084x |
|
Firma Oponiarska DĘBICA SA
WAR:DBC
|
0.032x |
|
ANGLE plc
OTCQX:ANPCF
|
-0.385x |
Annual Cash Flow Conversion Efficiency for GenoFocus Inc (2014–2024)
The table below shows the annual cash flow conversion efficiency of GenoFocus Inc from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩23.77 Billion | ₩2.87 Billion | 0.121x | +166.11% |
| 2023-12-31 | ₩26.36 Billion | ₩-4.82 Billion | -0.183x | +7.37% |
| 2022-12-31 | ₩23.89 Billion | ₩-4.71 Billion | -0.197x | -191.01% |
| 2021-12-31 | ₩35.28 Billion | ₩-2.39 Billion | -0.068x | -9.88% |
| 2020-12-31 | ₩39.77 Billion | ₩-2.45 Billion | -0.062x | -1818.94% |
| 2019-12-31 | ₩52.12 Billion | ₩-167.50 Million | -0.003x | -112.37% |
| 2018-12-31 | ₩60.21 Billion | ₩1.56 Billion | 0.026x | +22.28% |
| 2017-12-31 | ₩64.22 Billion | ₩1.36 Billion | 0.021x | +157.26% |
| 2016-12-31 | ₩62.52 Billion | ₩516.09 Million | 0.008x | -91.38% |
| 2015-12-31 | ₩29.79 Billion | ₩2.85 Billion | 0.096x | +423.17% |
| 2014-12-31 | ₩9.66 Billion | ₩-286.45 Million | -0.030x | -- |